Economic analysis of treating depression with nefazodone v. imipramine

British Journal of Psychiatry

Volumn 168, Issue JUNE, 1996, Pages 768-771

  Montgomery, S A ^a   Brown, Ruth E ^b   Clark, Michael ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b MEDTAP International Inc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; NEFAZODONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; ECONOMIC ASPECT; HUMAN;

EID: 0029953091     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.168.6.768     Document Type: Article

References (13)

1. AGUGLIA, E., CASACCHIA, M., CASSANO, G. B., et al (1993) Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. International Clinical Psychopharmacology, 8, 197-202.
2. ANTON, S. F., ROBINSON, D. S., ROBERTS, D. L., et al (1994) Long-term treatment of depression with nefazodone. Psychopharmacology Bulletin, 30, 165-169.
3. CHARTERED INSTITUTE OF PUBLIC FINANCE AND ACCOUNTANCY (CIPFA) (1992) Health Database 1992, Volume 1, Financial Overview. Specialty Cost Analysis Section 4.3. London: Chameleon Press.
4. DRUG TARIFF (1995) March 1995. National Health Service England and Wales. London: HMSO.
5. GRIMSLEY, S. R. & JANN, M. W. (1992) Paroxetine, sertraline and fluvoxamine: New selective serotonin reuptake inhibitors. Clinical Pharmacy, 11, 930-957.
6. HATZIANDREU, E., BROWN, R. E., REVICKI, D. A., et al (1994) Cost utility of maintenance treatment of recurrent depression with sertraline versus episodic treatment with dothiepin. PharmacoEconomics, 5, 249-264.
7. JONSSON, B. & BEBBINGTON, P. E. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry, 164, 665-673.
8. KIND, P. & SORENSEN, J. (1993) The costs of depression. International Clinical Psychopharmacology, 7, 191-195.
9. MONTGOMERY, S. A., HENRY, J., MCDONALD, G., et al (1994) Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. International Clinical Psychopharmacology, 9, 47-53.
10. NETTEN, A. & DENNETT, J. (compilers) (1995) Unit Costs of Community Care. University of Kent at Canterbury: Personal Social Services Research Unit (PSSRU).
11. SIMON, G., WAGNER, E. & VONKORFF, M. (1995) Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs. Journal of Clinical Epidemiology, 48, 363-373.
12. SONG, F., FREEMANTLE, N., SHELDON, T. A., et al (1993) Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal, 306, 683-686.
13. STEWART, A. (1994) Antidepressant phannacotherapy: Cost comparison of SSRIs and TCAs. British Journal of Medical Economics, 7, 67-79.